Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS National Framework Agreement - Inhalation Anaesthetics and Vaporisers
Period of framework agreement: 1st February 2025 to 31st January 2027, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
with option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£73,044,952 estimated from lot values | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Baxter Healthcare Ltd | 00461365 | ~£73,044,952 estimated from lot values | LOBBYIST WA Communications Ltd (3 quarters) |
| Piramal Critical care Limited | 05160306 | ~£73,044,952 estimated from lot values | - |
Government spending data: These suppliers have received £291,166,425 in 8,371 payments (over £25k) from The Christie NHS Foundation Trust, Department of Health and Social Care, NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust and 13 more public bodies (2010-04-01 to 2026-03-31).